CDC report shows decrease in US tobacco product use

Mar.23.2022
CDC report shows decrease in US tobacco product use
CDC's survey showed a decrease in overall tobacco product usage among American adults, but 19% still use some form of tobacco.

According to foreign media on March 17, 2022, report that...

 

The Centers for Disease Control and Prevention (CDC) released the findings of their weekly report on incidence and mortality rates today, revealing an overall decrease in the use of commercial tobacco products, combustible tobacco products, cigarettes, e-cigarettes, and two or more tobacco products among U.S. adults from 2019 to 2020. However, as of 2020, nearly one-fifth of adults (estimated 47.1 million) reported current (daily or some days) tobacco product use, including 30.8 million smokers.

 

In order to assess recent estimates of tobacco product use among adult Americans aged 18 and over, the Center for Disease Control and Prevention (CDC) analyzed data from the 2020 National Health Interview Survey. The survey evaluated the use of five tobacco products: cigarettes, cigars (cigars, small cigars, or filtered little cigars), pipes (regular pipes, water pipes, or hookahs), electronic cigarettes, and smokeless tobacco.

 

A recent study has found that by 2020, 19.0% of American adults will have used at least one tobacco product, which is slightly lower than the 20.8% reported in 2019. Despite this decrease, cigarettes remain the most commonly used product at 12.5%, followed by e-cigarettes at 3.7%, cigars at 3.5%, smokeless tobacco at 2.3%, and pipes at 1.1%.

 

We have made significant progress in preventing and reducing tobacco use in this country through the use of validated strategies and implementation of effective policies," said Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention and Health Promotion. "Although adult tobacco use has dramatically decreased, our work is far from over. We must continue to address tobacco-related health disparities and inequities to ensure that everyone has the opportunity to be as healthy as possible.

 

Despite a decrease, the usage of combustible products remains high.

 

A new study reveals that smoking rates among adults have dropped to their lowest point since 1965, when it was 42%. While the percentage of adults who smoke has decreased from 14.0% in 2019 to 12.5% in 2020, nearly 31 million American adults still reported smoking in 2020. Among adults who currently use tobacco products, over three-quarters use combustible products like cigarettes, cigars, and pipes, which are the leading cause of tobacco-related illness, disability, and death in the United States.

 

In the United States, between 2019 and 2020, there was a decrease in the percentage of adults using other tobacco products, including e-cigarettes, which went from 4.5% to 3.7%. The use of combustible tobacco products also decreased from 16.7% to 15.2%. Additionally, the percentage of people using two or more tobacco products also decreased from 3.9% to 3.3%.

 

Factors that may contribute to a decline in smoking and tobacco use include influential anti-tobacco media campaigns such as the CDC's "Tips From Former Smokers," smoke-free policies, and policies that restrict the supply of specific types of tobacco products, such as flavored products.

 

Differences in the use of tobacco products

 

By 2020, significant differences still exist in the use of tobacco products among various adult population groups in the United States. These groups include:

 

Men (5%).

 

Nine percent of adults aged 25 to 44 years old.

 

34.9% of adult non-Hispanic American Indian/Alaska Native individuals and 1% of adult non-Hispanic individuals are classified as belonging to other races.

 

Three percent of adults live in rural (non-urban) areas.

 

The highest level of education attained by adults is a General Educational Development (GED) certificate, which accounts for 40.5%.

 

25.2% of adults have a household annual income less than $35,000.

 

Adults who identify as lesbian, gay, or bisexual (1%).

 

27.3% of adults do not have health insurance, while 6% rely on Medicaid or other forms of subsidized health insurance.

 

Four percent of adults have disabilities.

 

Nearly 30% of adults experience anxiety and 6% experience depression on a regular basis.

 

(Source: Center for Disease Control)

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16